Creative Medical Technology
CELZ | NASDAQ
$0.52
-$0.01 (-1.53%)
At close: Nov 16, 2026, 4:00 PM ET
$0.52
$0.00 (+0.02%)
After-hours:
Nov 16, 2026, 7:55 PM ET
-1.53%
(1D)No price chart data available for 1D timeframe.
Rating
30
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #801/1021 (Top 78%)
Key Statistics
Market Data
Market Cap $3.95M
1D Range
0.52 0.56
52W Range
0.52 3.05
Valuation (TTM)
PE -0.27
PB 0.57
EV/EBITDA 0.59
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $0.00
Cash Flow
FCF Yield -161.9%
SBC Adj. FCF Yield -161.9%
SBC Impact N/A
Margins
Gross Margin -697.1%
Operating Margin -165569.9%
FCF Margin -213248.6%
Growth (CAGR)
Revenue 3Y | 5Y -50.4% |
-39.7%
Dil EPS 3Y | 5Y 32.7% |
41.4%
FCF 3Y | 5Y -8.9% |
1.4%
Returns
ROA -102.7%
ROE -102.3%
ROIC -110.1%
Financial Health
Net Cash
$6.85M
Current Ratio 23.66
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, ...
Sector Healthcare
Industry Biotechnology
Employees 4
IPO Date Nov 6, 2015
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove CELZ